DJIA 16,811.37 34.94 0.21%
NASDAQ 4,749.15 -32.12 -0.67%
S&P 500 1,983.46 -3.59 -0.18%
market minute promo

MannKind Corp (NASDAQ: MNKD)

3.12 -0.07 (-2.19%)

REAL-TIME: Last trade at

company name or ticker

Recent Quotes

MNKD $3.12 -2.19%
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $3.20
Previous Close $3.19
Daily Range $3.08 - $3.23
52-Week Range $2.98 - $7.88
Market Cap $1.3B
P/E Ratio -9.67
Dividend (Yield) $0.00 (0.0%)
Volume 3,019,924
Average Daily Volume 4,623,313
Current FY EPS -$0.28




Drug Makers

MannKind Corp (MNKD) Description

A biopharmaceutical company focused on the development and commercialization of therapeutic products for diseases such as diabetes and cancer. Website:

News & Commentary

Another Month, Another Crushing Decline for MannKind

Pessimism remains firm on Wall Street, with MannKind stock losing another 15% in September.

MannKind: Weekly Data Updates For Prescriptions

MannKind Silent on Debt Conversion, Suggesting Costly Cash Settlement

14 Healthcare Stocks Fundstrat Is Buying

MannKind Cuts Its Headcount, But Will It Matter?

MannKind is laying-off workers to reduce expenses, but without sales growth these cuts may not be enough.

Why Sanofi's Afrezza Marketing Strategy Is Brilliant

Diabetic Investor On MannKind: 'There's A Reason Why So Many People Are Short This Stock'

MannKind: Weekly Data Updates For Prescriptions

3 Biotech Stocks Short-Sellers Have Targeted the Most

These three biotech stocks have bull's-eyes on their backs courtesy of short-sellers.

These Healthcare Stocks Could Be Primed for a Short Squeeze

Should pessimists in these healthcare stocks be shaking in their boots?

See More MNKD News...

MNKD's Top Competitors

MNKD $3.12 (-2.19%)
Current stock: MNKD
AMGN $141.43 (-1.65%)
Current stock: AMGN
GILD $97.40 (-1.87%)
Current stock: GILD
BIIB $276.30 (-3.58%)
Current stock: BIIB